🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 112 of 200 · A–Z by INN

  1. lopinavir

    KALETRA

    ORAL FDA: approved · EMA: approved

    J05AR10

  2. lopinavir + ritonavir

    KALETRA AbbVie

    TGA: approved

  3. loracarbef

    LORABID

    ORAL FDA: approved

  4. loratadine

    ALLEREZE Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  5. lorazepam

    LORAZEPAM Amneal Pharma Europe Ltd

    INJECTION FDA: approved

  6. lorcaserin hydrochloride

    LORCASERIN HYDROCHLORIDE

    ORAL FDA: approved

  7. lorlatinib

    LORVIQUA Pfizer Australia Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    L01ED05

  8. losartan potassium

    LOSARTAN POTASSIUM Teva Pharma GmbH

    ORAL FDA: approved

  9. loteprednol etabonate

    EYSUVIS Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  10. lotilaner

    XDEMVY Tarsus Pharmaceuticals

    OPHTHALMIC FDA: approved

  11. lotions

    NULL

    TGA: approved

  12. lovastatin

    LOVASTATIN Teva Pharma GmbH

    ORAL FDA: approved

  13. low-dose

    NMPA: clinical trials

  14. loxapine

    ADASUVE

    INHALATION FDA: approved · EMA: approved

    N05AH01

  15. loxapine hydrochloride

    LOXITANE C Teva Pharma GmbH

    INJECTION FDA: approved

  16. loxapine succinate

    LOXITANE ELITE PHARMACEUTICALS INC /NV/

    ORAL FDA: approved

  17. lu af28996

    NMPA: clinical trials

  18. lubiprostone

    LUBIPROSTONE Amneal Pharma Europe Ltd

    ORAL FDA: approved · NMPA: clinical trials

  19. lubricating agent

    LUBRI-GEL Lacuna Pharma Pty Ltd

    TGA: approved

  20. lucar-

    NMPA: clinical trials

  21. lucinactant

    SURFAXIN

    INTRATRACHEAL FDA: approved

  22. luliconazole

    LUZU

    TOPICAL FDA: approved

  23. lumacaftor

    ORKAMBI Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    R07AX30

  24. lumacaftor + ivacaftor

    ORKAMBI Vertex Pharmaceuticals (Australia) Pty.

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources